1.99

2.93% -0.06

After Hours: 1.99

Arcadia Biosciences Inc (RKDA)

Overview News Price History Financials Discussions Forecast Stock Split

Arcadia Biosciences Inc stock is currently priced at $1.99, with a 24-hour trading volume of 5,387. It has seen a -2.93% decreased in the last 24 hours and a -0.50% declined in the past month. The chart indicates a potential bearish trend, as the stock is below the $2.03 pivot point. If it approaches the $1.98 support level, significant changes may occur.

Previous Close:

$2.05

Open:

$1.97

24h Volume:

5,387

Market Cap:

$2.71M

Revenue:

$5.67M

Net Income/Loss:

$-13.98M

P/E Ratio:

-0.0926

EPS:

-21.5

Net Cash Flow:

$-15.30M

1W Performance:

+4.73%

1M Performance:

-0.50%

6M Performance:

-39.88%

1Y Performance:

-67.90%

1D Range:

$1.9608

$2.06

52W Range:

$1.8512

$7.30

Arcadia Biosciences Inc Stock (RKDA) Company Profile

Name

Arcadia Biosciences Inc

Sector

Consumer Defensive (245)

Industry

Packaged Foods (66)

Phone

530 756 7077

Address

202 Cousteau Place, Suite 105, Davis, CA

Employee

Twitter

@ArcadiaAg

Next Earnings Date

2024-05-09

Latest SEC Filings

RKDA's Discussions on Twitter

Arcadia Biosciences Inc Stock (RKDA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-17-20	Reiterated	H.C. Wainwright	Buy
May-12-17	Downgrade	Piper Jaffray	Overweight → Neutral
Jun-09-15	Initiated	Credit Suisse	Outperform
Jun-09-15	Initiated	Piper Jaffray	Overweight

Arcadia Biosciences Inc Stock (RKDA) Latest News

Arcadia Biosciences (RKDA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Zacks Investment Research

Zacks Industry Outlook Highlights like West Fraser Timber, CalMaine Foods, GrowGeneration, Hydrofarm and Arcadia Biosciences

Zacks Investment Research

5 Agriculture - Products Stocks to Watch in a Challenging Industry

Zacks Investment Research

Arcadia Biosciences Inc Stock (RKDA) Financials Data

Arcadia Biosciences Inc (RKDA) Revenue 2024

RKDA reported a revenue (TTM) of $5.67 million for the quarter ending December 31, 2023, a -39.68% decline year-over-year.

Arcadia Biosciences Inc (RKDA) Net Income 2024

RKDA net income (TTM) was -$13.98 million for the quarter ending December 31, 2023, a +9.07% increase year-over-year.

Arcadia Biosciences Inc (RKDA) Cash Flow 2024

RKDA recorded a free cash flow (TTM) of -$15.30 million for the quarter ending December 31, 2023, a -8.90% decrease year-over-year.

Arcadia Biosciences Inc (RKDA) Earnings per Share 2024

RKDA earnings per share (TTM) was -$14.13 for the quarter ending December 31, 2023, a +45.34% growth year-over-year.

Arcadia Biosciences, Inc. produces and markets plant-based health and wellness products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health and wellness products, and their viability for industrial applications. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring bath and body care. The company was incorporated in 2002 and is headquartered in Davis, California.